Rabdano, S.; Ruzanova, E.; Makarov, D.; Vertyachikh, A.; Teplykh, V.; Rudakov, G.; Pletyukhina, I.; Saveliev, N.; Zakharov, K.; Alpenidze, D.;
et al. Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine. Vaccines 2024, 12, 100.
https://doi.org/10.3390/vaccines12010100
AMA Style
Rabdano S, Ruzanova E, Makarov D, Vertyachikh A, Teplykh V, Rudakov G, Pletyukhina I, Saveliev N, Zakharov K, Alpenidze D,
et al. Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine. Vaccines. 2024; 12(1):100.
https://doi.org/10.3390/vaccines12010100
Chicago/Turabian Style
Rabdano, Sevastyan, Ellina Ruzanova, Denis Makarov, Anastasiya Vertyachikh, Valeriya Teplykh, German Rudakov, Iuliia Pletyukhina, Nikita Saveliev, Konstantin Zakharov, Diana Alpenidze,
and et al. 2024. "Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine" Vaccines 12, no. 1: 100.
https://doi.org/10.3390/vaccines12010100
APA Style
Rabdano, S., Ruzanova, E., Makarov, D., Vertyachikh, A., Teplykh, V., Rudakov, G., Pletyukhina, I., Saveliev, N., Zakharov, K., Alpenidze, D., Vasilyuk, V., Arakelov, S., & Skvortsova, V.
(2024). Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine. Vaccines, 12(1), 100.
https://doi.org/10.3390/vaccines12010100
